4//SEC Filing
HAUMANN BRETT K 4
Accession 0000899243-20-014618
CIK 0001631650other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 7:17 PM ET
Size
7.5 KB
Accession
0000899243-20-014618
Insider Transaction Report
Form 4
HAUMANN BRETT K
Director
Transactions
- Award
Stock Option (right to buy)
2020-05-27+25,453→ 25,453 totalExercise: $17.11Exp: 2030-05-26→ Common Stock (25,453 underlying) - Award
Common Stock, $0.0001 par value
2020-05-27+13,313→ 19,563 total
Footnotes (2)
- [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest as to 1/3rd of the RSUs on each anniversary of the grant date, assuming continuous service as a director until each such vesting date.
- [F2]The shares subject to the option will vest and become exercisable as to 1/36th of the shares subject to the option on each monthly anniversary of the grant date, assuming continuous service as a director until each such vesting date.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001607733
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 7:17 PM ET
- Size
- 7.5 KB